Karen Kaucic
Chief Tech/Sci/R&D Officer at PPD, INC.
Karen Kaucic active positions
Companies | Position | Start | End |
---|---|---|---|
PPD, INC. | Chief Tech/Sci/R&D Officer | - | - |
Corporate Officer/Principal | 2009-11-30 | - |
Career history of Karen Kaucic
Former positions of Karen Kaucic
Companies | Position | Start | End |
---|---|---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | President | - | - |
Training of Karen Kaucic
The Ohio State University | Doctorate Degree |
Statistics
International
United States | 4 |
Operational
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | Commercial Services |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
- Stock Market
- Insiders
- Karen Kaucic
- Experience